Top Markets
Coin of the day
Kadimastem Ltd Kadimastem Ltd

Kadimastem Ltd

KDST
株式のランク #41016
Kadimastem Ltd is a biopharmaceutical company focused on pioneering... Kadimastem Ltd is a biopharmaceutical company focused on pioneering regenerative medical treatments. These therapies are developed using cells sourced from human embryonic stem cells, primarily targeting neurodegenerative diseases. Its development pipeline features AstroRx, a clinical-grade human astrocyte product currently undergoing Phase 1/2a clinical trials for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. Additionally, the company is advancing IsletRx, a clinical-grade pancreatic islet cell therapy intended for the treatment of diabetes. Incorporated in 2008, Kadimastem is headquartered in Ness Ziona, Israel.
株価
$12.16
最終同期: 2025-10-30
時価総額
$50.98K
変化(1日)
-0.10%
変化(1年)
56.95%
IL
取引 Kadimastem Ltd (KDST)

カテゴリー

Kadimastem Ltd(KDST)の配当利回りの履歴
Kadimastem Ltd(銘柄コード: KDST)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Kadimastem Ltd(KDST)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)